Journal Watch · Frontiers in Immunology · 2026

Regulation of MRGPRX2-mediated mast cell function by competence-stimulating peptide 1 and pro-adrenomedullin peptide.

These differences in G protein-biased and balanced signaling may dictate the ability of CSP-1 and PAMP-12 to contribute to host defense and ACD, respectively.

Amponnawarat A, Sutradhar S, Chompunud Na Ayudhya C et al.Frontiers in Immunology4 min readPharma relevance 40/100

DOI: 10.3389/fimmu.2026.1781889PMID: 41924265Study type: preclinical (animal / model) study

TL;DR

These differences in G protein-biased and balanced signaling may dictate the ability of CSP-1 and PAMP-12 to contribute to host defense and ACD, respectively.

Key findings

  • By contrast, CSP-1 caused ~5-fold increase in β-arrestin recruitment and ~20% receptor internalization.<h4>Conclusion</h4>These findings demonstrate that PAMP-12 and CSP-1 utilize shared G proteins to induce ERK phosphorylation and degranulation.
  • However, they display substantial differences in their ability to cause MRGPRX2 phosphorylation, β-arrestin recruitment, receptor internalization and desensitization.
  • These differences in G protein-biased and balanced signaling may dictate the ability of CSP-1 and PAMP-12 to contribute to host defense and ACD, respectively.

Numbers at a glance (from the abstract)

60%20%50-fold5-fold

Every figure above is taken verbatim from the abstract below. Check the full text for denominators, confidence intervals and subgroup detail.

What they did

The goals of this study were to determine if CSP-1 and PAMP-12 serve as balanced or biased MRGPRX2 agonists and to investigate the differences in receptor internalization and desensitization in response to these agonists.<h4>Methods</h4>Bioluminescence resonance energy transfer 2 (BRET2) in HEK293T cells expressing MRGPRX2 was utilized to investigate G protein coupling following MRGPRX2 activation. β-arrestin recruitment studies were performed using Transcriptional Activation Following Arrestin Translocation (Tango) assay. Effects of PAMP-12 and CSP-1 on MRGPRX2 phosphorylation, desensitization, receptor internalization, extracellular-signal-regulated kinase (ERK) phosphorylation and degranulation were determined in RBL cells stably expressing MRGPRX2.<h4>Results</h4>PAMP-12 and CSP-1 coupled to Gαq, Gαi1, and Gαi3 and induced ERK phosphorylation and degranulation at similar levels. However, PAMP-12 caused MRGPRX2 phosphorylation and desensitization, but CSP-1 did not. PAMP-12 caused ~50-fold increase in β-arrestin recruitment and this was associated with ~60% internalization of cell surface MRGPRX2.

Full abstract (original)

Background: <h4>Introduction</h4>Mas-related G protein-coupled receptor (GPCR)-X2 (MRGPRX2, mouse ortholog MrgprB2) is predominantly expressed in mast cells (MCs) and is activated by a wide range of cationic ligands such as bacterial quorum sensing molecules (QSMs) and pro-adrenomedullin peptide 9-20 (PAMP-12). Activation of MrgprB2 by competence-stimulating peptide-1 (CSP-1), a QSM produced by Gram-positive bacteria, has recently been shown to promote antibacterial immunity, whereas its activation by PAMP-12 has been implicated in allergic contact dermatitis (ACD) and itch. Mechanisms via which the activation of the same receptor by different agonists contributes to different functional outcomes are unknown. GPCR agonists that activate both the G protein and receptor phosphorylation-mediated β-arrestin pathways are known as balanced agonists but agonists that activate only the G proteins are known as G protein-biased agonists.

What they did: The goals of this study were to determine if CSP-1 and PAMP-12 serve as balanced or biased MRGPRX2 agonists and to investigate the differences in receptor internalization and desensitization in response to these agonists.<h4>Methods</h4>Bioluminescence resonance energy transfer 2 (BRET2) in HEK293T cells expressing MRGPRX2 was utilized to investigate G protein coupling following MRGPRX2 activation. β-arrestin recruitment studies were performed using Transcriptional Activation Following Arrestin Translocation (Tango) assay. Effects of PAMP-12 and CSP-1 on MRGPRX2 phosphorylation, desensitization, receptor internalization, extracellular-signal-regulated kinase (ERK) phosphorylation and degranulation were determined in RBL cells stably expressing MRGPRX2.<h4>Results</h4>PAMP-12 and CSP-1 coupled to Gαq, Gαi1, and Gαi3 and induced ERK phosphorylation and degranulation at similar levels. However, PAMP-12 caused MRGPRX2 phosphorylation and desensitization, but CSP-1 did not. PAMP-12 caused ~50-fold increase in β-arrestin recruitment and this was associated with ~60% internalization of cell surface MRGPRX2.

Results & conclusions: By contrast, CSP-1 caused ~5-fold increase in β-arrestin recruitment and ~20% receptor internalization.<h4>Conclusion</h4>These findings demonstrate that PAMP-12 and CSP-1 utilize shared G proteins to induce ERK phosphorylation and degranulation. However, they display substantial differences in their ability to cause MRGPRX2 phosphorylation, β-arrestin recruitment, receptor internalization and desensitization. These differences in G protein-biased and balanced signaling may dictate the ability of CSP-1 and PAMP-12 to contribute to host defense and ACD, respectively.

Abstract © the authors / Frontiers in Immunology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.3389/fimmu.2026.1781889 · PubMed 41924265.

Why it matters for pharma & biotech

  • Directly relevant to teams in small-molecule drug discovery — the abstract reports new data in that space, so competitive and pipeline teams should read the full text.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Modalities & themes detected: small-molecule drug discovery

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The work is preclinical. Results in animal or cell models frequently do not translate directly to human efficacy or safety.

Frequently asked questions

What did this Frontiers in Immunology study find?

These differences in G protein-biased and balanced signaling may dictate the ability of CSP-1 and PAMP-12 to contribute to host defense and ACD, respectively.

What type of study is this?

It is a preclinical (animal / model) study, published in Frontiers in Immunology in 2026. The goals of this study were to determine if CSP-1 and PAMP-12 serve as balanced or biased MRGPRX2 agonists and to investigate the differences in receptor internalization and desensitization in response to these agonists.<h4>Methods</h4>Bioluminescence resonance energy transfer 2 (BRET2) in HEK293T cells expressing MRGPRX2 was utilized to investigate G protein coupling following MRGPRX2 activation.

Where can I read the original paper?

The original is at the publisher via DOI 10.3389/fimmu.2026.1781889. PubMed ID: 41924265. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Amponnawarat A, Sutradhar S, Chompunud Na Ayudhya C et al.. Regulation of MRGPRX2-mediated mast cell function by competence-stimulating peptide 1 and pro-adrenomedullin peptide.. Frontiers in Immunology (2026). DOI: 10.3389/fimmu.2026.1781889.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/regulation-of-mrgprx2-mediated-mast-cell-function-by-competence-stimulat-781889/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides